Search
Filter Results
- Resource Type
- Article1
- Journal1
- Journal Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Research Support, U.S. Gov't, Non-P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Science1
Search Results
Sort by
- ArticleWatson SJ, Berger PA, Akil H, Mills MJ, Barchas JD.Science. 1978 Jul 07;201(4350):73-6.Endogenous opiate-like peptides (endorphins) are putative neuroregulators located throughout the mammalian brainstem. There is some evidence for their role in pain, stress, and affect. We report that the opiate antagonist, naloxone, alters some schizophrenic symptoms. In a double-blind, cross-over study, naloxone produced decreases in auditory hallucinations in some schizophrenic patients. This finding supports the hypothesis that the endorphins may play a roll in modulating hallucinations in a highly selected subgroup of chronically hallucinating schizophrenic patients.